Lanza R. (ed.), Weissman I. (ed.), Thomson J. (ed.) — Handbook of Stem Cells (vol. 1) Embryonic Stem Cells :: Электронная библиотека попечительского совета мехмата МГУ

Главная Ex Libris Книги Журналы Статьи Серии Каталог Wanted Загрузка ХудЛит Справка Поиск по индексам Поиск Форум

Авторизация

Поиск по указателям

Lanza R. (ed.), Weissman I. (ed.), Thomson J. (ed.) — Handbook of Stem Cells (vol. 1) Embryonic Stem Cells

Обсудите книгу на научном форуме

Нашли опечатку?
Выделите ее мышкой и нажмите Ctrl+Enter

Название: Handbook of Stem Cells (vol. 1) Embryonic Stem Cells

Авторы: Lanza R. (ed.), Weissman I. (ed.), Thomson J. (ed.)

Аннотация:

The Handbook of Stem Cells, edited by Robert Lanza and colleagues, is an ambitious new text that achieves extraordinary completeness and inclusiveness...the editors have succeeded in putting together a reference that is broad enough in scope, but sufficiently detailed and rigorous, to be of real interest to both new and seasoned investigators in the field.

Язык:

Рубрика: Биология/

Статус предметного указателя: Готов указатель с номерами страниц

ed2k: ed2k stats

Год издания: 2004

Количество страниц: 843

Добавлена в каталог: 16.04.2007

Операции: Положить на полку | Скопировать ссылку для форума | Скопировать ID

Предметный указатель

$G_{\alpha}Z$ -deficient mice      1: 589—591 1: 1:
$\beta$ -Catenin      2: 66 2:
$\beta$ -Catenin in epidermal stem cell differentiation      2: 251
$\beta$ -Catenin in gastrointestinal development      1: 362—363
$\beta$ -Catenin in intestinal stem cell regulation      2: 532—533
$\beta$ -Catenin in neural crest cell development      2: 228
$\beta$ -Catenin in skin development      2: 263
$\beta$ -Galactosidase      1: 575 2: 2:
ABO blood group antigens      1: 667 1:
Access to human ES cell lines for research      1: 793—798
Activin A      1: 483—485 1: 1:
Adeno-associated viruses      2: 792 2:
Adenoma, colorectal      2: 535—541
Adipose tissue, adipogenesis      2: 429—431
Adipose tissue, amniotic fluid progenitor cell-derived adipocytes      2: 176
Adipose tissue, as stem cell source      2: 425 2:
Adipose tissue, disorders of      2: 425
Adipose tissue, ES cell differentiation into      1: 329—333
Adipose tissue, function      2: 425
Adipose tissue, osteoblast differentiation and      1: 332—333
Adipose tissue, preadipocytes      2: 425
Adipose tissue, statin effects      1: 332
Adipose tissue, stromo-vascular faction      2: 425 (see also “Processed lipoaspirate cells”)
Adrenal steroids      2: 221
Adult stem cells      1: 22
Adult stem cells in adult neovascularization      2: 461
Adult stem cells, cell fate decisions      2: 84—85 2:
Adult stem cells, central nervous system      2: 219—222
Adult stem cells, definition      2: 21—22
Adult stem cells, diabetes treatment potential      2: 731—735
Adult stem cells, differentiation      2: 2 2: 2:
Adult stem cells, distribution      2: 475
Adult stem cells, Drosophila cell fate signaling      2: 62
Adult stem cells, ethical issues in research      1: 766
Adult stem cells, formation      2: 14 2:
Adult stem cells, function      2: 83 2: 2: 2:
Adult stem cells, gene expression profiles      2: 26—33 2:
Adult stem cells, hematopoietic, age-related changes in      2: 337—343
Adult stem cells, homing capacity      2: 714
Adult stem cells, immortal strand      2: 274
Adult stem cells, isolation and characterization      2: 479
Adult stem cells, kidney      2: 478—479
Adult stem cells, liver      2: 483—491
Adult stem cells, lung      2: 547—553
Adult stem cells, neural      1: 513 2: 2:
Adult stem cells, nuclear transfer from      1: 642—643 1:
Adult stem cells, origins      2: 84
Adult stem cells, pancreatic      2: 515—519
Adult stem cells, phenotype change      2: 139—143
Adult stem cells, potency and plasticity      2: 14—16 2: 2: 2:
Adult stem cells, stem cell niche hypothesis      2: 59
Adult stem cells, therapeutic potential      1: 805 2:
Adult stem cells, transdifferentiation, potential      2: 147
Adult stem cells, transdifferentiation, vs. cell fusion      2: 154—155
Adventitious virus assay      2: 808 2: 2:
Advocacy, patient      1: 805—806
AFT024 cell line      2: 624
Age-related changes      2: 28
Age-related changes in cell cycle      2: 338
Age-related changes in cytokine network      2: 342
Age-related changes in hematopoietic stem cells      2: 337—343
Age-related changes in immune function      2: 745 2:
Age-related changes in keratinocyte stem cells      2: 763
Age-related changes in mammary epithelium      2: 269—270
Age-related changes in mesenchymal stem cells      2: 301—302
Age-related changes in telomere length      2: 127—128 2: 2: 2:
Age-related changes in thymus      1: 679—680
Airway hyperreactivity      1: 591—592
Albumin in liver development      1: 360—361
Alkaline phosphatase      1: 575
Allantois      1: 194 1: 1:
Alloantigen compatibility      1: 664 1:
Allogeneic transplants      2: 685
Allogeneic transplants of HS cells for immune reconstitution      2: 751—752
Allograft transplantation into immune-privileged sites      1: 668
Allograft transplantation, skin      1: 733
Alpha-fetoprotein in liver development      1: 360
Alveolar bone      2: 287
Alzheimer’s disease      1: 246—247 2: 2: 2:
AMD3100 molecule      2: 601
Ameloblasts      2: 279 2:
Amniocentesis      2: 175
Amniotic fluid, composition      2: 175
Amniotic fluid, diagnostic role      2: 175
Amniotic fluid, progenitor cells, differentiation potential      2: 176—178 2: 2:
Amniotic fluid, progenitor cells, isolation and characterization      2: 175—176
Amniotic fluid, progenitor cells, sternness      2: 176
Amniotic fluid, research opportunities      2: 178—179
Amphibians      2: 704
Amphiregulin      1: 585
Amyotrophic lateral sclerosis      1: 246 1: 1: 1:
Anagen follicles      see “Hair follicle stem cells”
Analysis of variance      2: 646
Anemia      2: 337—338
Angioblasts      2: 594
Angiocysts      1: 323
Angiogenesis      1: 323 2:
Angiogenesis after ES cell transplantation      1: 716—717
Angiogenesis in adult      2: 460—465
Angiogenesis in bone tissue engineering      2: 773
Angiogenesis in myocardial regeneration      2: 450
Angiogenesis in tumors      2: 378
Angiogenesis, current status of experimental systems      1: 317
Angiogenesis, mesenchymal stem cells in      2: 305
Angiogenesis, skeletal stem cells in      2: 419
Angiogenesis, stem cell recruitment for      2: 377—383
Angiopoietin      2: 457
Antigen-presenting cells      1: 666
Antigen-presenting cells as proof of plasticity      2: 14
Antigen-presenting cells, cell markers      1: 565—569
Antigen-presenting cells, cell sorting techniques      2: 611
Antigen-presenting cells, hematopoietic stem cell isolation      2: 616—617
Antitrypsin deficiency      1: 387
Aorta-gonad-mesonephros region development      2: 418—419
Aorta-gonad-mesonephros region development, hematopoiesis in      2: 159 2: 2:
Ap1 transcription factors      1: 290
Ap2 transcription factors      1: 396—397
Apc protein      1: 175—176
Apocrine glands      2: 245
Arteriogenesis      2: 455—456
Aryl hydrocarbon receptor nuclear translocator (ARNT)      1: 91 1: 1:
Asthma      1: 591
Astrocytes      1: 244 2:
Astrocytes in neural stem cell formation      2: 220
Astrocytes, CNS development      1: 238
Ataxia telangiectasia      2: 119 2:
ATP-binding cassette transporter      2: 330 2: 2:
ATPase chromatin-remodeling complexes      1: 70—72 1:
Autografts, osteochondral      2: 773
Autografts, skin      1: 732—733 1: 1: 2: 2:
Autografts, skin, cultivation      2: 764—765
Autografts, skin, cultured epidermal autografts      2: 764 2:
Autologous transplant      2: 685
Autologous transplant of HS cells for immune reconstitution      2: 751—752
Avian stem cells      471—477
Axon regeneration      1: 704
B cells in graft rejection      1: 666
B cells, age-related changes      2: 745 2: 2:
B cells, development      1: 296—297 2: 2: 2: 2:
B cells, development, common lymphoid progenitor in      2: 357—358
B cells, development, transcription regulation in      2: 95—100
B cells, differentiation      2: 95—98 2:
B cells, gene activation      2: 98—99
B cells, immune reconstitution by HS cell implant      2: 751—754
B cells, lineage conversion      2: 364
B cells, origin      1: 296—297 2: 2:
B cells, Pax5-deficient      2: 87
B cells, telomere length      2: 133 2:
B-cdc2      2: 119 2:
Barrett’s metaplasia      2: 139 2:

Basic helix-loop-helix proteins      2: 193 2: 2: 2: 2:
Basic helix-loop-helix proteins in neural patterning      1: 207 1: 1: 1: 1: 1:
Basic helix-loop-helix proteins in olfactory neurogenesis      2: 237
Basic helix-loop-helix proteins, repressor genes      1: 211—212 1:
Bayh — Dole Act      1: 793 1: 1: 1: 1:
BB9 antibody      2: 617
BF—2 transcription factor      1: 340—341
Bisbenzimidazole      see “Hoescht-33342”
Bladder progenitor cells      2: 565—600
Blast colony-forming cell      1: 94 1: 2: 2: 2:
Blastocoele      1: 129
Blastocoele, Xenopus animal cap      1: 483
Blastocyst in hematopoietic development      1: 11
Blastocyst, axis specification during preimplantation      1: 144—146
Blastocyst, clone-derived ES cell      1: 651—652
Blastocyst, cumulus cell-derived      1: 647
Blastocyst, early in vitro research      1: 1—2 1:
Blastocyst, embryogenesis      1: 27 1:
Blastocyst, formation      1: 129 1: 1:
Blastocyst, moral status      1: 750—751
Blastocyst, potency      1: 573 1:
Blastocyst, stem cells      1: 92f
Blastocyst, trophectoderm cells      1: 193
Blastocyst, trophoblast derivation from      1: 479—480
Blastomeres, developmental potency      1: 146
Blastomeres, early formation and properties      1: 129—131
Blastomeres, polarization      1: 143
Blood group antigens      1: 667
Blood transplantation with umbilical cord blood      2: 181—185
BMP—2      1: 306—307
BMP—2 in bone tissue engineering      2: 772—773
BMP—2 in cartilage tissue engineering      2: 774
BMP—2 in in vivo osteogenesis      2: 433—41—34
BMP—2 in neural crest cell development      2: 227 2:
BMP—4      1: 188
BMP—4 in cardiomyogenesis      1: 306—307
BMP—4 in hematopoietic development      2: 160 2: 2:
BMP—4 in neural crest cell development      2: 207
BMP—4 to enhance hematopoiesis      1: 282
BMP—7 in bone tissue engineering      2: 772
BMP—7 in cartilage tissue engineering      2: 774
BMP—8b      1: 188
BMP—8b in cardiomyogenesis      1: 308
BMP—8b in central nervous system development      2: 192
BMP—8b in germ cell specification      1: 658
BMP—8b in neurogenesis      1: 206 1: 1:
BMP—8b in olfactory progenitor differentiation      2: 240
BMP—8b in skin development      2: 262—263
BMP—8b in stromal cell differentiation      2: 420
BMP—8b, early research      2: 299
Bone marrow      1: 737—738
Bone marrow, aging effects      2: 338 2:
Bone marrow, cell transdifferentiation      2: 142 2:
Bone marrow, common myeloid progenitors in      2: 367—368 2:
Bone marrow, early stem cell research      2: 1
Bone marrow, government regulation of stem cell products      2: 805
Bone marrow, hematopoietic stem cell population      2: 595 2:
Bone marrow, liver repopulation with marrow-derived progenitors      2: 488 2:
Bone marrow, long term cultures      2: 668
Bone marrow, mesenchymal stem cell culture from      2: 302
Bone marrow, multipotent adult progenitor cells      2: 293
Bone marrow, multipotent cell population in      2: 722—724
Bone marrow, muscle stem cell precursors in      2: 398—399
Bone marrow, origins and early development      2: 167
Bone marrow, pancreatic $\beta$ -cells from      2: 517
Bone marrow, postnatal skeletal stem cells      2: 416—418
Bone marrow, precursors of insulin-producing cells in      2: 734
Bone marrow, proangiogenic stem cell recruitment from      2: 377—383
Bone marrow, slide population      2: 329—335
Bone marrow, stem cell differentiation      2: 415
Bone marrow, stem cell homing      2: 599—600
Bone marrow, stem cell plasticity      2: 2—3 2: 2:
Bone marrow, stem cell plasticity in kidney      2: 475—477
Bone marrow, stem cell plasticity, gut repopulation      2: 528—530
Bone marrow, stem cell populations      2: 23 2: 2:
Bone marrow, stromal cell implants      2: 415 2: 2:
Bone marrow, tissue engineered repair, cell sources for      2: 783—784
Bone marrow, tissue-engineered repair      2: 303
Bone marrow, transplantation      2: 368—369
Bone marrow, transplantation in muscular dystrophy treatment      2: 722—724
Bone marrow, vasculature, skeletal stem cells in      2: 418—419 2:
Bone marrow-derived cells, bone morphogenic protein (BMP)      2: 804
Bone, autogenous grafts      2: 772
Bone, development      2: 415
Bone, marrow formation      1: 296—297 1:
Bone, osteoclast distribution      1: 295
Bone, osteogenesis      2: 431—434
Bone, spine      2: 777
Bone, structure and function      1: 285
Bone, tissue-engineered repair      2: 303 2: 2:
Bovine serum      1: 779—780
Brain-derived neurotrophic factor      2: 220
Breast cancer      2: 269 2: 2:
Bulge cells      2: 6 2: 2: 2: 2:
Burns      1: 731
Burns, classification      2: 762f 2:
Burns, epidemiology      1: 731
Burns, skin grafts      1: 732—733 2: 2:
C-kit in hepatic stem cell activation      2: 505—506
C-kit in primordial germ cell proliferation      1: 459—460
C-kit, cardiac      2: 711 2: 2:
C-kit, hematopoietic stem cell phenotype      2: 324 2:
c-myc      1: 585 2:
C/EBP-p transcription factor      2: 87—88 2:
C/EBP-p transcription factor in leukemogenesis      2: 316
C2C12 cells      2: 721—722
Cadherins      1: 175—176
Cadherins in hematopoietic stem cell niches      2: 64
Cancer, breast      2: 269 2: 2:
Cancer, cell fusion processes in      2: 154
Cancer, colorectal      2: 535—541
Cancer, small intestine      2: 1 2: 2: “Specific “Specific
Cardiac stem cells      2: 450—41—51
Cardiac stem cells, current conceptualization      2: 711
Cardiac stem cells, differentiation      2: 711 2:
Cardiac stem cells, distribution      2: 711—713
Cardiac stem cells, mobilization      2: 715 2:
Cardiac stem cells, myocardial regeneration strategies      2: 715—717
Cardiomyocytes, cardiovascular system development      2: 449
Cardiomyocytes, clinical potential      1: 713—714 1: 1:
Cardiomyocytes, culture conditions to increase yield      1: 714—715 1: 1: 1:
Cardiomyocytes, differentiation      1: 105—107 1: 1: 2:
Cardiomyocytes, ES cell-derived      1: 713 1: 1:
Cardiomyocytes, future research      1: 718—719
Cardiomyocytes, myocardial regeneration      2: 450 2:
Cardiomyocytes, syncytium repair      1: 713
Cardiomyocytes, transplantation      1: 713—714 1:
Cardiomyogenesis, cardiac crescent formation      1: 306—307 1:
Cardiomyogenesis, cell differentiation in      1: 105—107 1: 1:
Cardiomyogenesis, embryonic heart development      1: 309—311 1:
Cardiomyogenesis, gap junctional communication in      1: 105—107
Cardiomyogenesis, heart tube formation and remodeling      1: 307—309 1: 1:
Cardiomyogenesis, patterning      1: 306
Cardiomyogenesis, precursor cells      1: 305—311
Cardiomyogenesis, transcription factors      1: 305—306 1:
Cardiotrophin—1 (CT—1)      1: 28
Cardiotrophin—1 (CT—1) in gp30/gpl30 dimerization      1: 28—29
Cardiovascular system, embryonic development      1: 91 1: 1: 2:
Cardiovascular system, myocardial regeneration      2: 449—41—53 2:
Cardiovascular system, processed lipoaspirate cells in cardiac myogenesis      2: 436—41—37
Cardiovascular system, stem cell populations      2: 449—451
Cardiovascular system, tissue engineering to regenerate cardiac muscle      2: 786
Cardiovascular system, tissue transplant strategies for infarcted myocardium      2: 714 (see also “Cardiac stem cells” “Cardiomyocytes” “Cardiomyogenes
Cartilage, articular      2: 773 2:
Cartilage, chondrogenesis      2: 434—41—36
Cartilage, disorders of      2: 773
Cartilage, long-term cultures      1: 489—490
Cartilage, spine      2: 777—778
Cartilage, tissue-engineered repair      2: 303 2: 2:
Cavitation      1: 133 1: 1:

1 2 3 4 5 6 7 8 9 10 11 12

О проекте